Cardiovascular Health

Heart disease is the leading cause of death in women — and one of the most preventable. It has been the number one cause of death in women every year since 1984, yet prevention and screening still get far too little focus. Too often it’s found only after a heart attack or stroke.

Women are more likely than men to die after a heart attack — especially younger women — and less likely to receive prompt, aggressive cardiac care. Heart symptoms in women (nausea, indigestion, jaw or back pain, fatigue, breathlessness, with or without chest pain) are often blamed on stress or anxiety: in one study, 53% of women versus 37% of men were told their symptoms were not heart-related.

The menopause turning point

Before menopause, estrogen helps protect the heart — supporting nitric oxide and flexible blood vessels, a healthy vessel lining, a favorable cholesterol profile, and better insulin sensitivity. As estrogen falls, those protections fade, and blood pressure, cholesterol, visceral (belly) fat, and insulin resistance tend to rise. Midlife is the window where prevention has the most to offer.

Where hormone therapy honestly fits

Guidelines do not recommend starting HRT for the sole purpose of preventing heart disease — guidance based largely on the original Women’s Health Initiative, which used oral conjugated estrogen plus a synthetic progestin in women on average more than a decade past menopause. Started earlier, and with transdermal, body-identical formulations, the risk picture changes substantially, and there appears to be a “window of opportunity” when HRT is most likely to be heart-neutral to protective. The handout walks through the timing hypothesis, the trials in younger women (DOPS, KEEPS, ELITE), the added risk of early or premature menopause, and why the route of estrogen matters when cardiovascular risk is elevated.

Screening before symptoms

We don’t wait for a heart attack to look. The handout covers what we screen for in midlife women — lipoprotein(a), ApoB, a standard lipid panel and hs-CRP, and a coronary artery calcium (CAC) score for selected patients — and what helps most: Mediterranean / DASH-style eating, aerobic activity plus strength training, and a focus on strength and metabolic health rather than the number on the scale.

What’s in this guide

Our two-page Cardiovascular Health patient handout covers:

• Why heart disease is missed in women — and the symptoms that get dismissed
• How estrogen protects the heart, and what shifts at menopause
• The honest take on hormone therapy and heart disease, including the “window of opportunity” and the WHI re-analyses
• The screening we recommend before symptoms appear — Lp(a), ApoB, hs-CRP, and CAC scoring
• The lifestyle changes with the strongest evidence for your heart
• 21 peer-reviewed and guideline references

Download the full PDF below.